MIR7111

Across TCGA pan-cancer cohorts, MIR7111 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated MIR7111 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher MIR7111 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR7111 expression acts as an unfavorable survival marker, although some lineages such as BLCA and DLBC show a favorable association.

KIRC, ACC, and BLCA are the cancer types where MIR7111 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Median	All	0.480	0.735	<.001	116	view →
ACC	DFS	Median	All	0.299	0.631	<.001	80	view →
BLCA	DFS	Tertile	All	0.549	0.382	<.001	64	view →
LIHC	DFS	Quartile	All	0.439	0.621	.001	34	view →
COAD	OS	Median	II,III,IV	0.717	0.849	.002	20	view →
SKCM	DFS	Tertile	II,III,IV	0.478	0.744	.002	19	view →
PRAD	DFS	Median	All	0.843	0.919	.006	18	view →
BRCA	DFS	Tertile	IV	0.299	0.648	.018	14	view →
SARC	OS	Median	All	0.649	0.804	.006	13	view →
UVM	OS	Median	III,IV	0.607	1.000	.009	10	view →
LGG	DFS	Quartile	All	0.658	0.810	.002	9	view →
DLBC	DFS	Median	All	0.921	0.429	.017	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

MIR7111–KIRC (DFS)

Open the KIRC breakdown →